These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Epinephrine for acute decompensated heart failure and low output state: friend or foe? Morici N; Sacco A; Oliva F; Ferrari S; Paino R; Milazzo F; Frigerio M; Pirola R; Klugmann S; Mafrici A Int J Cardiol; 2011 Jun; 149(3):384-5. PubMed ID: 21439660 [No Abstract] [Full Text] [Related]
5. [Current role of non-digitalis inotropic agents in acute and chronic treatment of heart failure]. Dei Cas L; Nodari S; Raddino R; Metra M; Pelà G; Nardi M Cardiologia; 1994 Mar; 39(3):209-15. PubMed ID: 8039201 [No Abstract] [Full Text] [Related]
6. [Positive inotropic therapy of cardiac failure: old and new drugs, controversies and tests]. Sfrisi C; Cocco G Clin Ter; 1984 Oct; 111(2):159-67. PubMed ID: 6239739 [No Abstract] [Full Text] [Related]
7. Inotropic agents in the treatment of postoperative low cardiac output syndrome. Husedzinović I; Sutlić Z; Biocina B; Rudez I Acta Med Croatica; 1995; 49(4-5):201-5. PubMed ID: 8630454 [TBL] [Abstract][Full Text] [Related]
8. [New inotropic drugs]. Ferrari M; Cargnelli G; Piovan D; Bova S; Padrini R G Ital Cardiol; 1982; 12(2):139-46. PubMed ID: 6293904 [No Abstract] [Full Text] [Related]
9. Inodilator therapy for heart failure. Early, late, or not at all? Remme WJ Circulation; 1993 May; 87(5 Suppl):IV97-107. PubMed ID: 8097971 [TBL] [Abstract][Full Text] [Related]
10. French multicentre survey on the use of inotropes after cardiac surgery. Bastien O; Vallet B; Crit Care; 2005 Jun; 9(3):241-2. PubMed ID: 15987409 [TBL] [Abstract][Full Text] [Related]
11. [Positive inotropic agents in heart failure. Clinico-pharmacological evidence for medical practice]. Rohde LE; Ribeiro JP Arq Bras Cardiol; 1994 Dec; 63(6):537-42. PubMed ID: 7605243 [No Abstract] [Full Text] [Related]
12. [Use of inotropic agents in dilated cardiomyopathy]. Gorb GD; Zhdaniuk IuI; Makovskaia TE; Tsybul'nik ZI Klin Med (Mosk); 1989 Jan; 67(1):87-90. PubMed ID: 2654468 [No Abstract] [Full Text] [Related]
13. [Treatment of low cardiac output by phosphodiesterase inhibitors]. Lançon JP; Caillard B Agressologie; 1991; 32(1):81-2. PubMed ID: 2063988 [No Abstract] [Full Text] [Related]
14. Use of digoxin in diastolic heart failure. Dhir SK J Lab Clin Med; 2001 Oct; 138(4):277. PubMed ID: 11574822 [No Abstract] [Full Text] [Related]
16. [Hemodynamic effects of amrinone, dobutamine and dopamine in the cardiac low output syndrome following open-heart surgery]. Husedzinović I; Rumboldt Z; Ivancan V; Nikić N; Rudeź I; Biocina B; Sutlić Z Lijec Vjesn; 1995 Jun; 117 Suppl 2():32-4. PubMed ID: 8649147 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of cardiac insufficiency: inotropic stimulation or relief of cardiac load? (Report 1)]. Mareev VIu Kardiologiia; 1993; 33(12):6-14. PubMed ID: 7910868 [No Abstract] [Full Text] [Related]
18. Pharmacologic management of heart failure: positive inotropic agents. Cross JA Crit Care Nurs Clin North Am; 1993 Dec; 5(4):589-97. PubMed ID: 8297549 [TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of phosphodiesterase III inhibitors: another reason to promote their use? Simkova V; Radermacher P; Barth E Crit Care; 2007; 11(3):139. PubMed ID: 17572916 [TBL] [Abstract][Full Text] [Related]